|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 1/18 | |
| A61K 38/48 | |||
| C12N 9/64 | |||
| A61K 47/60 |
| (11) | Patento numeris | 2504349 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10784769.1 |
| Europos patento paraiškos padavimo data | 2010-11-24 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-10-03 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-02-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2010/068112 |
| Data | 2010-11-24 |
| (87) | Numeris | WO 2011/064247 |
| Data | 2011-06-03 |
| (30) | Numeris | Data | Šalis |
| 09176881 | 2009-11-24 | EP | |
| 264486 P | 2009-11-25 | US |
| (72) |
WIENDAHL, Matthias, Karl, Dietrich, DK
SEJERSGAARD, Lars, DK
BOGSNES, Are, DK
|
| (73) |
Novo Nordisk Health Care AG,
Andreasstrasse 15, 8050 Zürich,
CH
|
| (54) | METHOD OF PURIFYING PEGYLATED PROTEINS |
| METHOD OF PURIFYING PEGYLATED PROTEINS |